You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國同輻(01763.HK):原子高科擬收購廣州中大中山醫科技開發股份
格隆匯 10-12 21:50

格隆匯10月12日丨中國同輻(01763.HK)發佈公吿,公司旗下一間於全國中小企業股份轉讓系統上市的附屬公司,原子高科股份有限公司(股份代號:430005)於2021年10月9日召開的公司第六屆董事會第二十五次會議審議通過了《關於收購廣州中大中山醫科技開發有限公司股權的議案》,為獲得廣州中大中山醫科技開發有限公司所持工業廠房所有權及間接持有的廣州市原子高科同位素醫藥有限公司(以下簡稱廣州高科)股權,原子高科擬收購開發公司100%的股權。

開發公司註冊地址為廣州市經濟技術開發區科學城崖鷹石路10號B座400室,註冊資本702.48萬元。經營範圍主要為科技信息諮詢服務;科技項目代理服務;醫學研究和試驗發展;藥品研發;化工產品批發(危險化學品除外);儀器儀表批發;電子元器件批發;化工產品零售(危險化學品除外);電子元器件零售;貿易代理;房屋租賃。

開發公司持有廣州高科29.74%的房屋產權,並間接持有廣州高科部分股權,每年通過房屋租金、對外投資(廣州高科分紅)收益約360萬元左右,公司盈利能力比較穩定,財務狀況較好,不會對公司未來財務及經營產生不利影響。廣東省是核藥物使用大省,且隨着粵港澳大區的建立,諸多利好政策率先在大灣區實行先試先行。目前,廣州高科的生產規模已不能滿足日益增長的市場需求,本次收購可為廣州高科後續研發、生產等工作開展提供場地基礎,有利於廣州高科未來發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account